【摘要】 目的探讨降高血压药物联合抗焦虑抑郁药物万拉法新治疗老年性原发高血压伴焦虑抑郁障碍的疗效及安全性。方法纳入2006年10月2008年10月我院门诊和住院诊治的老年性原发高血压伴焦虑抑郁障碍患者100例,随机分为干预组和对照组。所有患者给予常规降压药物治疗,干预组另外给予万拉法新治疗,治疗12周后评价临床疗效。结果干预组临床降压疗效总有效率94.0%,显著高于对照组总有效率80.0%(P<0.05)。两组患者的收缩压、舒张压与治疗前比较均显著改善(P<0.05),干预组患者与对照组比较血压明显改善(P<0.05)。干预组临床抗焦虑抑郁疗效总有效率96.0%,显著高于对照组总有效率58.0%(P<0.05)。两组均无明显的不良反应。结论降高血压药物联合抗焦虑抑郁药物万拉法新治疗老年性原发高血压伴焦虑抑郁障碍疗效肯定,且安全可靠,值得临床推广应用。更多还原

【Abstract】 Objective To investigate the efficacy and safety of antihypertensive drugs combined with anti-anxiety depression drug venlafaxine for treatment of patients with senile primary hypertension(SPH)and anxiety-depression disorder(AD).Methods One hundred SPH patients with AD with were randomly divided into an intervention group and a control group.All cases were given antihypertensive drugs medication,while the intervention group was given venlafaxine.After 12 weeks of treatment,the clinical efficacy was evaluated.Results The antihypertensive efficacy rate in the intervention group was 94.0%,significantly higher than that of the control group 80.0%(P<0.05).The systolic blood pressure(SBP)and diastolic blood pressure(DBP)of the two groups significantly improved compared with those before treatment(P<0.05),and the intervention group’ SBP and DBP improved significantly than those of the control group(P<0.05).The total effective rate of anti-anxiety depression efficacy of the intervention group was 96.0%,significantly higher than that of the control group 58.0%(P<0.05).The two groups had no significant adverse reactions.Conclusion For patients with senile primary hypertension and anxiety-depression disorder,the combination medication with antihypertensive drugs and venlafaxine was safe,reliable and worthy of clinical application.更多还原